Tisagenlecleucel versus historical standard therapies for pediatric relapsed/refractory acute lymphoblastic leukemia
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tisagenlecleucel versus historical standard therapies for pediatric relapsed/refractory acute lymphoblastic leukemia
Authors
Keywords
-
Journal
Journal of Comparative Effectiveness Research
Volume -, Issue -, Pages -
Publisher
Future Medicine Ltd
Online
2020-07-01
DOI
10.2217/cer-2020-0069
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Prognostic factors for survival after relapsed acute lymphoblastic leukemia (ALL): A Children’s Oncology Group (COG) study.
- (2019) Susan R. Rheingold et al. JOURNAL OF CLINICAL ONCOLOGY
- Patient-reported quality of life after tisagenlecleucel infusion in children and young adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: a global, single-arm, phase 2 trial
- (2019) Theodore W Laetsch et al. LANCET ONCOLOGY
- Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
- (2018) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia
- (2017) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rates and Trends of Pediatric Acute Lymphoblastic Leukemia — United States, 2001–2014
- (2017) David A. Siegel et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Phase I/Phase II Study of Blinatumomab in Pediatric Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia
- (2016) Arend von Stackelberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Matching Adjusted Indirect Comparisons To Assess Comparative Effectiveness Of Therapies: Usage In Scientific Literature And Health Technology Appraisals
- (2016) H Thom et al. VALUE IN HEALTH
- Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
- (2014) Shannon L. Maude et al. NEW ENGLAND JOURNAL OF MEDICINE
- How I treat relapsed childhood acute lymphoblastic leukemia
- (2012) F. Locatelli et al. BLOOD
- Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves
- (2012) Patricia Guyot et al. BMC Medical Research Methodology
- Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients
- (2012) Maurizio Miano et al. LEUKEMIA & LYMPHOMA
- Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
- (2012) James E. Signorovitch et al. VALUE IN HEALTH
- Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemia
- (2011) N. Hijiya et al. BLOOD
- Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia
- (2011) David O’Connor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Outcome of children and adolescents with relapsed acute lymphoblastic leukaemia and non-response to salvage protocol therapy: A retrospective analysis of the ALL-REZ BFM Study Group
- (2010) Arend von Stackelberg et al. EUROPEAN JOURNAL OF CANCER
- Long-Term Outcome in Children With Relapsed Acute Lymphoblastic Leukemia After Time-Point and Site-of-Relapse Stratification and Intensified Short-Course Multidrug Chemotherapy: Results of Trial ALL-REZ BFM 90
- (2010) Gesche Tallen et al. JOURNAL OF CLINICAL ONCOLOGY
- Effect of mitoxantrone on outcome of children with first relapse of acute lymphoblastic leukaemia (ALL R3): an open-label randomised trial
- (2010) Catriona Parker et al. LANCET
- Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemia
- (2009) Franco Locatelli et al. BRITISH JOURNAL OF HAEMATOLOGY
- Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study
- (2009) Richard H. Ko et al. JOURNAL OF CLINICAL ONCOLOGY
- A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia
- (2009) N Hijiya et al. LEUKEMIA
- Factors influencing survival after relapse from acute lymphoblastic leukemia: a Children's Oncology Group study
- (2008) K Nguyen et al. LEUKEMIA
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started